Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Thomas Bieber's publication output changed over time?
ScholarIQpublication output · 2003–2018
Output grew200% over the shown period — from 1 works in 2003 to 3 in 2018.
1
1
1
1
1
1
1
2
3
200320042006200820122014201520162018
What are the most-cited papers on Thomas Bieber?
ScholarIQmost cited works
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
S. G. O. Johansson, Thomas Bieber, Ronald Dahl, Peter S. Friedmann, Bobby Q. Lanier, Richard F. Lockey, C. Motala, José António Ortega Martell, Thomas A.E. Platts‐Mills, Johannes Ring, Frank Thien, Paul Van Cauwenberge, Hywel C Williams
Journal of Allergy and Clinical Immunology. 20042,327 Citations
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu
New England Journal of Medicine. 20162,067 CitationsOPEN ACCESS
Atopic dermatitis
Stephan Weidinger, Lisa A. Beck, Thomas Bieber, Kenji Kabashima, Alan D. Irvine
Nature Reviews Disease Primers. 20181,499 Citations
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin
New England Journal of Medicine. 20141,414 Citations
Related on ScholarIQ
DB Engineering & Consulting (Germany)
Institution
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
Paper
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Paper
Atopic Dermatitis
Paper
Atopic dermatitis
Paper
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Paper